BMRN
Biomarin·NASDAQ
--
--(--)
--
--(--)
5.76 / 10
Netural
Fund flow analysis scores 8.05/10, indicating exceptionally strong fund flow dynamics. Bullish trends in overall, block, Small, Medium, and Extra-large contrast with bearish signals in Large, suggesting highly favorable liquidity momentum. Analyst perspective reveals overwhelmingly bullish analyst consensus with strong conviction. Rating breakdown: Strong Buy(100.0%) from 1 analyst assessments, supported by 3.47 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-20
InstitutionCanaccord Genuity
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for BMRN?
- BMRN holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.76/10 (Netural).
